The purpose of this document is to provide a set of recommendations on therapeutic interchange and substitution of pharmaceutical products, including with biosimilars.
|Place of Publication||The Hague, Netherlands|
|Publisher||International Pharmaceutical Federation|
|Number of pages||7|
|Publication status||Published - 2 Sep 2018|
- Policy statement
- pharmaceutical selection
- Drug selection